See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2021_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 36,730,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 125,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 749,000 |
| 4 | LiabilitiesCurrent | 11,578,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,278,380 |
| 9 | ResearchAndDevelopmentExpense | 19,040,351 |
| 10 | remainder_Expenses | 1,565,517 |
| 11 | remainder_Revenues | 9,381,963 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 37,604,000 |
| 1 | Liabilities | 11,578,000 |
| 2 | Expenses | 26,884,248 |
| 3 | Revenues | 9,381,963 |
| 4 | StockholdersEquity | 26,026,000 |
| 5 | NetIncome | -17,502,285 |
| 6 | ComprehensiveNetIncome | -17,502,285 |
| 7 | BaseVar | 42,724,106 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.60 |
| 9 | EconomicCapitalRatio | 2.75 |
Edgar->Model Mapping
Feature Distribution
Change over Time
